Literature DB >> 16291922

Treatment of dementia.

R Overshott1, A Burns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16291922      PMCID： PMC1765710          DOI： 10.1136/jnnp.2005.082537

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  20 in total

Review 1.  Evidence-based pharmacotherapy of Alzheimer's disease.

Authors:  John Grimley Evans; Gordon Wilcock; Jacqueline Birks
Journal:  Int J Neuropsychopharmacol       Date:  2004-07-01       Impact factor: 5.176

2.  Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.

Authors:  Peter Paul De Deyn; Ira R Katz; Henry Brodaty; Benjamin Lyons; Andrew Greenspan; Alistair Burns
Journal:  Clin Neurol Neurosurg       Date:  2005-10       Impact factor: 1.876

3.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

Authors:  I McKeith; T Del Ser; P Spano; M Emre; K Wesnes; R Anand; A Cicin-Sain; R Ferrara; R Spiegel
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

Review 4.  Nonpharmacologic interventions for psychotic symptoms in dementia.

Authors:  Jiska Cohen-Mansfield
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-12       Impact factor: 2.680

5.  Emerging therapies for vascular dementia and vascular cognitive impairment.

Authors:  Timo Erkinjuntti; Gustavo Román; Serge Gauthier; Howard Feldman; Kenneth Rockwood
Journal:  Stroke       Date:  2004-03-04       Impact factor: 7.914

6.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

7.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.

Authors:  S Auriacombe; J J Pere; Y Loria-Kanza; B Vellas
Journal:  Curr Med Res Opin       Date:  2002       Impact factor: 2.580

8.  Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.

Authors:  A Kurz; B Van Baelen
Journal:  Dement Geriatr Cogn Disord       Date:  2004-06-28       Impact factor: 2.959

9.  The effects of galantamine treatment on caregiver time in Alzheimer's disease.

Authors:  Mary Sano; Gordon K Wilcock; Bart van Baelen; Shane Kavanagh
Journal:  Int J Geriatr Psychiatry       Date:  2003-10       Impact factor: 3.485

10.  Atypical antipsychotics and risk of cerebrovascular accidents.

Authors:  Nathan Herrmann; Muhammad Mamdani; Krista L Lanctôt
Journal:  Am J Psychiatry       Date:  2004-06       Impact factor: 18.112
View more
  7 in total

1.  Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial.

Authors:  Marinda Henskens; Ilse M Nauta; Marieke C A van Eekeren; Erik J A Scherder
Journal:  Dement Geriatr Cogn Disord       Date:  2018-08-24       Impact factor: 2.959

2.  Cognitive function in a general population of men and women: a cross sectional study in the European Investigation of Cancer-Norfolk cohort (EPIC-Norfolk).

Authors:  Shabina A Hayat; Robert Luben; Stephanie Moore; Nichola Dalzell; Amit Bhaniani; Serena Anuj; Fiona E Matthews; Nick Wareham; Kay-Tee Khaw; Carol Brayne
Journal:  BMC Geriatr       Date:  2014-12-19       Impact factor: 3.921

3.  Computerized attention training for visually impaired older adults with dementia: a case study.

Authors:  Michael Chih Chien Kuo; Tsz Yang Fong; Cheuk Wing Fung; Chi To Pang; Lok Man So; Ka Ki Tse; Armstrong Tat San Chiu; King Yeung
Journal:  Dement Neuropsychol       Date:  2020-12

4.  A Web-Based Model to Predict a Neurological Disorder Using ANN.

Authors:  Abdulwahab Ali Almazroi; Hitham Alamin; Radhakrishnan Sujatha; Noor Zaman Jhanjhi
Journal:  Healthcare (Basel)       Date:  2022-08-05

Review 5.  Genetic aspects of Alzheimer disease.

Authors:  Thomas D Bird
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

6.  Novel Effects of Rosa damascena Extract on Patients with Neurocognitive Disorder and Depression: A Clinical Trial Study.

Authors:  Ebrahim Esfandiary; Zahra Abdolali; Victoria Omranifard; Mustafa Ghanadian; Reza Bagherian-Sararoud; Mohammad Karimipour; Behzad Mahaki; Shahriar Dabiri
Journal:  Int J Prev Med       Date:  2018-06-29

Review 7.  Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer's Disease.

Authors:  Shahul Hameed; Jong-Ling Fuh; Vorapun Senanarong; Esther Gunaseli M Ebenezer; Irene Looi; Jacqueline C Dominguez; Kyung Won Park; Ananda Krishna Karanam; Oliver Simon
Journal:  J Alzheimers Dis Rep       Date:  2020-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.